Skip to content

Multi center case registration study of PIB Gutong plaster in the treatment of joint pain based on the real world

Multi center case registration study of PIB Gutong plaster in the treatment of joint pain based on the real world

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046391
Enrollment
Unknown
Registered
2021-05-15
Start date
2018-12-02
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

joint pain

Interventions

Gutong patch combined with NSAID Group:No
Non-steroidal anti-inflammatory drug treatment group:No
Gutong patch alone group:No

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Chief complaint of neck, shoulder, lumbar spine or knee joint pain; 2. Age 16-80, gender unlimited; 3. Those who can be included in any one of the three treatment groups as determined by the researcher; 4. Oral treatment with the following common non-steroidal anti-inflammatory drugs is required: Aryl acids: diclofenac sodium/ibuprofen/loxoprofen sodium/etocoxib; Diaryl pyrazoles: celecoxib/erecoxib; Enolates: Meloxicam. 5. Signed the informed consent voluntarily, and agreed to participate in all visits according to the requirements of the study program.

Exclusion criteria

Exclusion criteria: 1. People who are allergic to any ingredient in this product or have contact dermatitis due to the use of plasters for many times (more than three times); 2. Patients with skin damage in the affected area (can be included in screening again after the skin damage is healed); 3. Long-term use of NSAIDs in the past; 4. Known peptic ulcer; 5. Pregnant or lactating women; 6. Participated in or is participating in other researchers within three months; 7. Other circumstances that the researcher considers unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
VAS score for pain in the affected area;SF-36 Health Survey Summary;

Secondary

MeasureTime frame
EQ - 5 d scale;Use of NSAID (Dosage and Duration);The pain began to ease;Pain relief time;Resurrection of range of motion;Primary types of joint pain;The occurrence of contact dermatitis;Incidence of adverse events;

Countries

China

Contacts

Public ContactWeng Xisheng

Peking Union Medical College Hospital

drwengxsh@163.com+86 13366200018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026